We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA's DTC Review Priorities Adapt to New PhRMA Principles
FDA's DTC Review Priorities Adapt to New PhRMA Principles
August 30, 2006
The FDA is making a major change to how it reviews DTC ads to account for an upsurge in the number of ads submitted since PhRMA’s new advertising principles went into effect Jan. 1, agency officials say.